COVID-19:Toyobo、Increases PCR test reagent production by 20 times: Ships to Chinese test reagent manufacturer

Genetics, flu, catastrophe, Pharmaceutical

Kyorin Pharma: Commissioned development of GeneSoC®:Agency for Medical Development (AMED)

flu, apparatus, catastrophe, Medical science, monitor

COVID-19: A Challenge for the Credit Insurance Industry: Atradius, Coface, Euler Hermes

solvency, bankruptcy, catastrophe, Company, Insurance

The University of Tokyo: New Corona May Have Effect on ‘Nafamostat’: Existing Treatment for Pancreatitis

flu, catastrophe, Pharmaceutical

Japanese flu drug appears ‘effective’ in coronavirus treatment in Chinese clinical trials

flu, catastrophe

Posts navigation